Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations

Neurobiology of Aging

Volumn 36, Issue 5, 2015, Pages 2005.e5-2005.e13

  Sabatelli, Mario ^a   Zollino, Marcella ^a   Conte, Amelia ^a   Del Grande, Alessandra ^a   Marangi, Giuseppe ^a   Lucchini, Matteo ^a   Mirabella, Massimiliano ^a   Romano, Angela ^a   Piacentini, Roberto ^a   Bisogni, Giulia ^a   Lattante, Serena ^a   Luigetti, Marco ^a   Rossini, Paolo Maria ^a,b   Moncada, Alice ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS S Raffaele Pisana and Casa di Cura S Raffaele   (Italy)

Author keywords

3' UTR; Amyotrophic lateral sclerosis; Fibroblast culture; TARDBP; TDP 43

Indexed keywords

TAR DNA BINDING PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; DNA BINDING PROTEIN; SUPEROXIDE DISMUTASE; TDP-43 PROTEIN, HUMAN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; C9ORF72 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FIBROBLAST; FUS GENE; GENE; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; SOD1 GENE; TARDBP GENE; CELL CULTURE; CELL INCLUSION; CYTOLOGY; FEMALE; GENE EXPRESSION; GENETICS; MALE; METABOLISM; MIDDLE AGED; MOTONEURON; MUTATION; PHYSIOLOGY;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CELLS, CULTURED; CYTOPLASM; DNA-BINDING PROTEINS; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; INCLUSION BODIES; MALE; MIDDLE AGED; MOTOR NEURONS; MUTATION; SUPEROXIDE DISMUTASE;

EID: 84933177290     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.02.009     Document Type: Article

References (37)

1. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Ota T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351:602-611.
2. Arai T., Hasegawa M., Nonoka T., Kametani F., Yamashita M., Hosokawa M., Niizato K., Tsuchiya K., Kobayashi Z., Ikeda K., Yoshida M., Onaya M., Fujishiro H., Akiyama H. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology 2010, 30:170-181.
3. Ayala Y.M., De Conti L., Avendano-Vazquez S.E., Dhir A., Romano M., D'Ambrogio A., Tollervey J., Ule J., Baralle M., Buratti E., Baralle F.E. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 2011, 30:277-288.
4. Barrett L.W., Fletcher S., Wilton S.D. Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements. Cell Mol. Life Sci. 2012, 69:3613-3634.
5. Blokhuis A.M., Groen E.J., Koppers M., van den Berg L.H., Pasterkamp R.J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013, 125:777-794.
6. Braak H., Ludolph A., Thal D.R., Del Tredici K. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord. Acta Neuropathol. 2010, 120:67-74.
7. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000, 1:293-299.
8. Budini M., Buratti E., Stuani C., Guarnaccia C., Romano V., De Conti L., Baralle F.E. Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its c-terminal Gln/Asn-rich region. J.Biol. Chem. 2012, 287:7512-7525.
9. D'Ambrogio A., Buratti E., Stuani C., Guarnaccia C., Romano M., Ayala Y.M., Baralle F.E. Functional mapping of the interaction between TDP-43 and hnRNP A2 invivo. Nucleic Acids Res. 2009, 37:4116-4126.
10. Davidson Y., Kelley T., Mackenzie I.R., Pickering-Brown S., Du Plessis D., Neary D., Snowden J.S., Mann D.M. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol. 2007, 113:521-533.
11. Gitcho M.A., Bigio E.H., Mishra M., Johnson N., Weintraub S., Mesulam M., Rademakers R., Chakraverty S., Cruchaga C., Morris J.C., Goate A.M., Cairns N.J. TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy. Acta Neuropathol. 2009, 118:633-645.
12. Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F., Morita M., Nakano I., Ota T., Tsuchiya K., Akiyama K. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008, 64:60-70.
13. Higashi S., Tsuchiya Y., Araki T., Wada K., Kabuta T. TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase. Neurochem. Int. 2010, 57:906-913.
14. Igaz L.M., Kwong L.K., Chen-Plotkin A., Winton M.J., Unger T.L., Xu Y., Neumann M., Trojanowski J.Q., Lee V.M. Expression of TDP-43 C-terminal fragments invitro recapitulates pathological features of TDP-43 proteinopathies. J.Biol. Chem. 2009, 284:8516-8524.
15. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.F., Camu W., Meininger V., Dupre N., Rouleau G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008, 40:572-574.
16. Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., Ding J., McCluskey L., Martinez-Lage M., Falcone D., Hernandez D.G., Arepalli S., Chong S., Schymick J.C., Rothstein J., Landi F., Wang Y.D., Calvo A., Mora G., Sabatelli M., Monsurrò M.R., Battistini S., Salvi F., Spataro R., Sola P., Borghero G., Galassi G., Scholz S.W., Taylor J.P., Restagno G., Chiò A., Traynor B.J. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010, 68:857-864. ITALSGEN Consortium.
17. Lagier-Tourenne C., Cleveland D.W. Rethinking ALS: the FUS about TDP-43. Cell 2009, 136:1001-1004.
18. Lee E.B., Lee V.M., Trjanowski J.Q. Gain or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci 2012, 13:38-50.
19. Mackenzie I.R., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., Kwong L.K., Forman M.S., Ravits J., Stewart H., Eisen A., McClusky L., Kretzschmar H.A., Monoranu C.M., Highley J.R., Kirby J., Siddique T., Shaw P.J., Lee V.M., Trojanowski J.Q. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 2007, 61:427-434.
20. Mackenzie I.R., Frick P., Neumann M. The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol. 2014, 127:347-357.
21. Maekawa S., Leigh P.N., King A., Jones E., Steele J.C., Bodi I., Shaw C.E., Hortobagyi T., Al-Sarraj S. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology 2009, 29:672-683.
22. Neumann M., Kwong L.K., Lee E.B., Kremmer E., Flatley A., Xu Y., Forman M.S., Troost D., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009, 117:137-149.
23. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
24. Nishimoto Y., Ito D., Yagi T., Nihei Y., Tsunoda Y., Suzuki N. Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. J.Biol. Chem. 2010, 285:608-619.
25. Nonaka T., Kametani F., Arai T., Akiyama H., Hasegawa M. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 2009, 18:3353-3364.
26. Pamphlett R., Luquin N., McLean C., Jew S.K., Adams L. TDP-43 neuropathology is similar in sporadic amyotrophic lateral sclerosis with or without TDP-43 mutations. Neuropathol. Appl. Neurobiol. 2009, 35:222-225.
27. Ravits J., Appel S., Baloh R.H., Barohn R., Brooks B.R., Elman L., Floeter M.K., Henderson C., Lomen-Hoerth C., Macklis J.D., McCluskey L., Mitsumoto H., Przedborski S., Rothstein J., Trojanowski J.Q., van den Berg L.H., Ringel S. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013, 14(Suppl 1):5-18.
28. Robertson J., Sanelli T., Xiao S., Yang W., Horne P., Hammondm R., Piormo E.P., Strong M.J. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neurosci. Lett. 2007, 420:128-132.
29. Sabatelli M., Madia F., Conte A., Luigetti M., Zollino M., Mancuso I., Lo Monaco M., Lippi G., Tonali P. Natural history of young-adult amyotrophic lateral sclerosis. Neurology 2008, 71:876-881.
30. Sabatelli M., Moncada A., Conte A., Lattante S., Marangi G., Luigetti M., Lucchini M., Mirabella M., Romano A., Del Grande A., Bisogni G., Doronzio P.N., Rossini P.M., Zollino M. Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013, 22:4748-4755.
31. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
32. Tan C.F., Eguchi H., Tagawa A., Onodera O., Iwasaki T., Tsujino A., Nishizawa M., Kakita A., Takahashi H. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol. 2007, 113:535-542.
33. Teyssou E., Takeda T., Lebon V., Boillée S., Doukouré B., Bataillon G., Sazdovitch V., Cazeneuve C., Meininger V., LeGuern E., Salachas F., Seilhean D., Millecamps S. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol. 2013, 125:511-522.
34. Tsuji H., Nonaka T., Yamashita M., Masuda-Suzukake M., Kametani F., Akiyama H., Mann D.M., Tamaoka A., Hasegawa M. Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Biochem. Biophys. Res. Commun. 2012, 417:116-121.
35. Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., Steinbart E., McCluskey L., Grossman M., Neumann M., Wu I.L., Yang W.S., Kalb R., Galasko D.R., Montine T.J., Trojanowski J.Q., Lee V.M., Schellenberg G.D., Yu C.E. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008, 7:409-416.
36. Yokoseki A., Shiga A., Tan C.F., Tagawa A., Kaneko H., Koyama A., Eguchi H., Tsujino A., Ikeuchi T., Kakita A., Okamoto K., Nishizawa M., Takahashi H., Onodera O. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 2008, 63:538-542.
37. Zhang Y.J., Xu Y.F., Cook C., Gendron T.F., Roettges P., Link C.D., Lin W.L., Tong J., Castanedes-Casey M., Ash P., Gass J., Rangachari V., Buratti E., Baralle F., Golde T.E., Dickson D.W., Petrucelli L. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7607-7612.